• Home
• ipf approved
• Current approved therapeutic strategies for IPF and LC treatment.

Current approved therapeutic strategies for IPF and LC treatment.

4.5 (95) · $ 27.50 · In stock

Current approved therapeutic strategies for IPF and LC treatment

Up-regulated SPP1 increases the risk from IPF to lung cancer via

Potential Therapeutic Targets of Resveratrol in the Prevention and

A comprehensive comparison of the safety and efficacy of drugs in

Valentina MASCIALE, PostDoc Position, Doctor of Philosophy, Polyclinic of Modena, Modena, PM, Department of Pediatric Surgery

Pie chart of modified MRC dyspnea score of chILD in Egyptian patients

Tissue fibrosis induced by radiotherapy: current understanding of

Idiopathic Pulmonary Fibrosis

Enrico CLINI, Professor in Respiratory Medicine, MD, Professor, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Medical and Surgical Sciences for Children and Adults